MED15-TFE3 rearranged renal cell carcinoma: a subtype of TFE3-rearranged renal cell carcinoma with unique clinicopathologic features and better prognosis
In contrast to traditional TFE3 rRCCs, MED15-TFE3 rRCCs may have distinctive clinicopathological features and a better prognosis. These findings enhance our understanding of the heterogeneity of TFE3 rRCCs.
Authors
- Enkui Duan (ORCID: https://orcid.org/0000-0002-2721-635X)
- Hongqian Guo
- Xiaopo Zhang (ORCID: https://orcid.org/0000-0003-2614-7425)
- Zhihong Deng (ORCID: https://orcid.org/0000-0002-1982-2616)
- Yanhao Xu (ORCID: https://orcid.org/0000-0002-7917-8885)
- Xiang Dong
- Weidong Gan
Institutions
- Nanjing Drum Tower Hospital (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1186/s12957-025-04048-x
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiangsu Commission of Health